metin, ekran görüntüsü, logo, yazı tipi içeren bir resim

Açıklama otomatik olarak oluşturuldu

 

 

Author Submission Guidelines and Writing Rules

Before submitting an article, please also review our journal's publication policies, publication ethics and article evaluation process. 

 

1. Journal of Molecular Virology and Immunology (JMVI) is periodically published, international scientific journal including experimental, observational, epidemiological studies, case reports and current reviews in the fields of medicine and health sciences.

2. JMVI is published quarterly on January, April, July and October and a volume is completed with four issues.

3. Archiving: All articles published in the journal are compiled in the archives of the “Milli Kütüphane | National Library of Turkey” in accordance with legal obligations.

4. JMVI is an open access international journal and no fee is charged to the authors during the process of article acceptance, evaluation and publication.

5. Editorial Board Members: http://www.tibbiviroloji.com/1/F4E.pdf.

6. Email address for contact: tibbiviroloji@gmail.com

7. Each submission will be reviewed by independent peer reviewers who are experts in their Fields. The names of referees and article authors who evaluate the article are kept confidential. The Editorial Board may make changes and corrections on the text of the manuscript without prejudice to the scientific content of the manuscript.

8. All submissions are screened by a similarity detection software (iThenticate). In the event of alleged or suspected research misconduct, e.g., plagiarism, citation manipulation, and data falsification/fabrication, the Editorial Board will follow and act in accordance with COPE guidelines.

9. Authors should upload Copyright Transfer Form and Author Contribution and Approval Forms to the online article system during the first submission. Author Contribution and Approval Form is a signed approval document stating the scientific contributions and responsibilities of the authors and the absence of any potential conflicts of interest and submit the manuscript together with the application documents.

10. Authors should declare and sign in the Author Contribution and Approval Form that the manuscript submitted is original, has not been previously published in another journal or accepted for publication and is not in the process of evaluation.

11. When submitting a revised version of a paper, the author must submit a detailed “Response to the reviewers” that states point by point how each issue (must write in a different color) raised by the reviewers has been covered and where it can be found (each reviewer’s comment, followed by the author’s reply and line numbers where the changes have been made) as well as an annotated copy of the main document.

12. All authors should be declare that the manuscript is original, has not been published elsewhere, and is not under evaluation for publication; and should be declare that I am not in a current or potential conflict of interest with any pharmaceutical company, biomedical device manufacturing company, or companies whose products and services may or may be related to the subject of the article. All authors are obliged to provide retractions or corrections of mistakes. All authors have significantly contributed to the research or other article forms http://www.tibbiviroloji.com/1/F3E.pdf.

13. Accepted manuscripts are copy-edited for grammar, punctuation, and format. A PDF proof of the accepted manuscript is sent to the corresponding author and their publication approval is requested within 5 days of their receipt of the proof.

14. Statements or opinions expressed in the manuscripts published in Journal of Molecular Virology and Immunology reflect the views of the author(s) and not the opinions of the publication owner, editor and the editorial board. Journal of Molecular Virology and Immunology, the publication owner, the editor and the editorial board disclaim any responsibility or liability for such materials.

15. The editorial and publication processes of the JMVI are formatted consideration with the guidelines of the International Council of Medical Journal Editors (ICMJE), the World Association of Medical Editors (WAME), the Council of Science Editors (CSE), the Committee on Publication Ethics (COPE), the European Association of Science Editors (EASE), and National Information Standards Organization (NISO).

16. Articles submitted to JMVI are accepted via tibbiviroloji@gmail e-mail address. Procedures and additional documents required during the submission steps are available at http://www.tibbiviroloji.com/. Additional documents:

·     Copyright Transfer Form

·     Author Contribution and Approval Form

·     Article sample for submission and title page

17. For the articles will be submitted for publication in the JMVI;

·     Originality, high scientific quality, and citation potential are the most important criteria for a manuscript to be accepted for publication.

·     To be contain up-to-date scientific data, information and references for the last five years.

·     Research and publication should be prepared in accordance with the general rules of ethics; Ethics committee approval and / or informed consent must be obtained from all research articles.

·     Researches should be conducted in accordance with universal ethical principles (World Medical Association Declaration of Helsinki).

18. Details of the congress or symposium to which the study was previously presented should be indicated.

19. Each individual listed as an author should fulfill the authorship criteria recommended by the International Committee of Medical Journal Editors (ICMJE - www.icmje.org). Those who do not meet all four criteria should be acknowledged in the title page of the manuscript. The ICMJE recommends that authorship be based on the following 4 criteria:

1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND

2. Drafting the work or revising it critically for important intellectual content; AND

3. Final approval of the version to be published; AND

4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

20. The publication languages of the JMVI are Turkish and English. A clear and understandable language should be used in the manuscript, and spelling and spelling mistakes should be taken care of.

21. In order to ensure that our journal can be cited as much as possible in the international indexes, the English abstract should be prepared with care; grammar, spelling and spelling errors. Abstract and Abstract sections for research articles; It should be written as a single paragraph including introduction-purpose, material-method, results, conclusions and comments.

22. The manuscripts to be sent for evaluation should be prepared in Times New Roman font with 12 pt and 1.5 line spacing. Each page should be numbered. The graphics and images sent must be high resolution (at least 300 dpi in JPG or TIFF format).

23. JMVI accepts articles in the categories of Research Article (Original Research), Case Report, Review and Letter to the Editor.

Research Articles;

·     Title Page: Manuscript title, author names and institutions, Copyright Transfer Form, Author Contribution and Approval Form.

·     Abstract (250-350 words)

·     Keywords in English

·     Introduction (200-500 words),

·     Material and Method (maximum 900 words)

·     Results (maximum 900 words)

·     Discussion (maximum 2000 words)

·     References (maximum 40)

·     The total manuscript text should not exceed 4600 words.

·     Meta-analysis studies will be considered as original research. Our journal does not accept research papers in the form of Short Communication.

·     Original manuscripts are evaluated “a double-blind peer-review process” by at least two reviewers.

Case Reports;

·     Title Page: Manuscript title, author names and institutions, Copyright Transfer Form, Author Contribution and Approval Form.

·     Abstract (100-250 words)

·     Keywords in English

·     Introduction (150-300 words)

·     Case report (maximum 600 words)

·     Discussion (maximum 600 words)

·     References (maximum 20)

·     The total text should not exceed 1750 words.

·     Case reports are evaluated “a double-blind peer-review process” by at least two reviewers.

Review Articles;

·     The number of authors should not be more than four,

·     Title Page: Manuscript title, author names and institutions, Copyright Transfer Form, Author Contribution and Approval Form.

·     Abstract (250-350 words)

·     Keywords in English

·     Introduction (150-400 words)

·     Review text including appropriate subtitles (4000-6000 words)

·     Results (50-150 words)

·     References (maximum 60)

·     The total manuscript text should not exceed 6850 words.

·     Review articles are evaluated “a double-blind peer-review process” by at least two reviewers.

Letters to the Editor;

·     Title Page: Manuscript title, author names and institutions, Copyright Transfer Form, Author Contribution and Approval Form.

·     Abstract (200-250 words)

·     Keywords in English

·     There should not be any sub-section in the letter text, and it should be written with the main text (maximum 650 words) and the result (50-100 words) paragraphs.

·     References (maximum 10)

·     The total text should not exceed 1000 words.

·     Letters are evaluated “a double-blind peer-review process” by at least two reviewers.

24. Title page: A separate title page should be submitted with all submissions and this page should include:

·     The full title of the manuscript as well as a short title (running head) of no more than 50 characters,

·     Name(s), affiliations, highest academic degree(s) and ORCID ID(s) of the author(s),

·     Name, address, telephone (including the mobile phone number) and email address of the corresponding author,

·     Acknowledgment of the individuals who contributed to the preparation of the manuscript but who do not fulfil the authorship criteria.

25. Each submission must be accompanied 3-4 keywords; The keywords should be selected from the National Library of Medicine, Medical Subject Headings (MESH) database (http://www.nlm.nih.gov/mesh/MBrowser.html) or check that it is appropriate.

26. Tables, figures, graphics and pictures should be numbered as "Tables 1, 2, 3" and "Figures 1, 2, 3". The number and descriptive title for the tables should be at the top of the table. The title and descriptive short texts of figures, graphics and pictures should be placed at the bottom.

27. References should be listed in order of appearance in the text and should be indicated in brackets and blue in the relevant places; [44,57]. References should be written in accordance with the "Vancouver" system of the American National Library of Medicine (http://www.nlm.nih.gov/). Examples:

·     For research articles: Pass RF, Fowler KB, Boppana SB, Britt WJ, Stagno S. Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J Clin Virol 2006; 35(2): 216-20. [doi: 10.0000/cms.0000.0]

·     For a book: Garinis GA, Menounos PG, Patrinos GP. Mutation Detection by Single Strand Conformation Polymorphism and Heteroduplex Analysis (Chapter-6). In: Patrinos GP, Ansorge W (eds), Molecular Diagnostics (1st edition). 2005, Elsevier, San Diego, California. pp:55-65.

·     For congress presentation: Sahiner F, Ozyurt M, Ergunay K. Phenotypic and genotypic identification of candida strains isolated as hospital infection pathogens in a military hospital in Turkey. 2nd International Congress of Pan-Arab Regional Group of Military Medicine, 4-9 December 2010, Jeddah-Kingdom of Saudi Arabia. Abstract Book, p:276, S26.

·     For Internet references: Zika Situation Report. Neurological Syndrome and Congenital Anomalies, 5 February 2016. World Health Organization, Geneva. Available at: http://apps.who.int/iris/bitstream. Accessed December 1, 2016.

·     For articles with more than six authors, "et al." should be used after the first six authors.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

©Copyright JMVI. Licensed by Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0).